The Procter & Gamble Company (NYSE:PG) Shares Bought by G&S Capital LLC

G&S Capital LLC boosted its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 3.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,827 shares of the company’s stock after purchasing an additional 485 shares during the quarter. G&S Capital LLC’s holdings in Procter & Gamble were worth $1,907,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Capital Investment Advisory Services LLC raised its holdings in Procter & Gamble by 4.9% in the fourth quarter. Capital Investment Advisory Services LLC now owns 36,681 shares of the company’s stock valued at $5,559,000 after buying an additional 1,711 shares during the period. Deuterium Capital Management LLC acquired a new position in Procter & Gamble in the fourth quarter worth about $675,000. Sweet Financial Partners LLC grew its position in shares of Procter & Gamble by 25.3% in the 1st quarter. Sweet Financial Partners LLC now owns 10,422 shares of the company’s stock worth $1,550,000 after acquiring an additional 2,106 shares in the last quarter. CX Institutional increased its stake in Procter & Gamble by 4.1% during the fourth quarter. CX Institutional now owns 33,743 shares of the company’s stock valued at $5,114,000 after purchasing an additional 1,320 shares during the last quarter. Finally, Oak Harbor Wealth Partners LLC raised its stake in Procter & Gamble by 11.1% during the fourth quarter. Oak Harbor Wealth Partners LLC now owns 30,891 shares of the company’s stock worth $4,682,000 after acquiring an additional 3,089 shares during the period. Institutional investors and hedge funds own 64.65% of the company’s stock.

Procter & Gamble Stock Performance

NYSE PG opened at $148.81 on Friday. The Procter & Gamble Company has a twelve month low of $122.18 and a twelve month high of $158.11. The company has a quick ratio of 0.39, a current ratio of 0.59 and a debt-to-equity ratio of 0.51. The stock has a market cap of $350.74 billion, a P/E ratio of 25.93, a PEG ratio of 3.91 and a beta of 0.42. The company’s 50-day simple moving average is $149.97 and its 200 day simple moving average is $147.40.

Procter & Gamble (NYSE:PGFree Report) last issued its earnings results on Friday, April 21st. The company reported $1.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.32 by $0.05. Procter & Gamble had a return on equity of 32.18% and a net margin of 17.69%. The business had revenue of $20.07 billion during the quarter, compared to analysts’ expectations of $19.32 billion. During the same period in the prior year, the firm posted $1.33 EPS. Procter & Gamble’s quarterly revenue was up 3.5% compared to the same quarter last year. As a group, research analysts forecast that The Procter & Gamble Company will post 5.86 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, May 15th. Stockholders of record on Friday, April 21st were paid a $0.9407 dividend. The ex-dividend date of this dividend was Thursday, April 20th. This represents a $3.76 dividend on an annualized basis and a dividend yield of 2.53%. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.91. Procter & Gamble’s payout ratio is 65.51%.

Insider Transactions at Procter & Gamble

In related news, CFO Andre Schulten sold 25,244 shares of the firm’s stock in a transaction on Monday, April 24th. The stock was sold at an average price of $155.27, for a total transaction of $3,919,635.88. Following the completion of the sale, the chief financial officer now directly owns 27,118 shares of the company’s stock, valued at approximately $4,210,611.86. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, CFO Andre Schulten sold 25,244 shares of the firm’s stock in a transaction that occurred on Monday, April 24th. The shares were sold at an average price of $155.27, for a total value of $3,919,635.88. Following the completion of the sale, the chief financial officer now owns 27,118 shares of the company’s stock, valued at $4,210,611.86. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Ma. Fatima Francisco sold 8,000 shares of the stock in a transaction on Monday, April 24th. The shares were sold at an average price of $156.84, for a total value of $1,254,720.00. Following the completion of the transaction, the chief executive officer now owns 9,343 shares in the company, valued at $1,465,356.12. The disclosure for this sale can be found here. Insiders have sold 95,093 shares of company stock valued at $14,821,930 in the last three months. 0.26% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

PG has been the topic of several analyst reports. Barclays raised their price target on shares of Procter & Gamble from $160.00 to $167.00 in a research note on Wednesday, April 26th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Procter & Gamble from $160.00 to $170.00 and gave the company a “buy” rating in a research report on Monday, April 24th. Jefferies Financial Group boosted their target price on shares of Procter & Gamble from $171.00 to $175.00 and gave the stock a “buy” rating in a report on Monday, April 24th. Morgan Stanley raised their target price on shares of Procter & Gamble from $160.00 to $174.00 and gave the stock an “overweight” rating in a report on Monday, April 24th. Finally, UBS Group upped their price target on Procter & Gamble from $170.00 to $180.00 and gave the company a “buy” rating in a report on Monday, April 24th. Five investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and an average price target of $161.50.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.